STOCK TITAN

[8-K] Functional Brands Inc. Reports Material Event

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Functional Brands Inc. reported a turnaround to profitability for 2025 and stronger liquidity. For the year ended December 31, 2025, revenue was $6,611,484 and net income was $758,478, compared with revenue of $6,566,455 and a net loss of $559,356 in 2024.

In the fourth quarter of 2025, revenue was $1,494,521 and net income reached $852,313, versus revenue of $1,680,096 and a net loss of $277,750 a year earlier. Basic net income per share was $0.08 for both the quarter and full year, while diluted earnings per share were $0.01.

Cash increased to $2,726,696 at year-end 2025 from $211,642, aided by $8,000,000 of proceeds from issuance of preferred stock. Total assets rose to $9,108,302, and stockholders’ equity improved to $1,541,331 from a deficit of $118,577, reflecting new equity capital and derivative liability movements.

Positive

  • None.

Negative

  • None.

Insights

Functional Brands swung to profit and rebuilt its balance sheet in 2025.

Functional Brands moved from a net loss of $559,356 in 2024 to net income of $758,478 in 2025 on essentially flat revenue of $6,611,484. The fourth quarter showed a similar pattern, with net income of $852,313 despite lower quarterly revenue.

Profitability relied heavily on non-operating items, including a $7,358,935 change in fair value of derivative liabilities and a $5,294,242 loss on issuance of preferred stock derivative liability. Core operations consumed cash, with operating cash flow of $(1,271,544) for the year.

The company significantly strengthened liquidity through financing, highlighted by $8,000,000 of preferred stock proceeds and a year-end cash balance of $2,726,696. Stockholders’ equity improved to $1,541,331, reversing a prior deficit. Future filings will clarify how the new Tru2u.health platform and product initiatives contribute to operating earnings beyond derivative and financing effects.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Full-year revenue 2025 $6,611,484 Year ended December 31, 2025 revenue, vs $6,566,455 in 2024
Full-year net income 2025 $758,478 Year ended December 31, 2025, vs net loss of $559,356 in 2024
Q4 2025 net income $852,313 Three months ended December 31, 2025, vs net loss of $277,750 in Q4 2024
Year-end cash 2025 $2,726,696 Cash at December 31, 2025, vs $211,642 at December 31, 2024
Stockholders’ equity 2025 $1,541,331 Equity at December 31, 2025, vs deficit of $118,577 at December 31, 2024
Preferred stock proceeds $8,000,000 Proceeds from issuance of preferred stock in 2025 financing activities
Net cash from financing $3,795,111 Net cash provided by financing activities for year ended December 31, 2025
Derivative liabilities balance $3,306,745 Current derivative liabilities at December 31, 2025 on balance sheet
derivative liabilities financial
"Derivative liabilities | | | 3,306,745 | | | | - |"
Derivative liabilities are obligations a company records when it owes money under financial contracts whose value depends on something else, like interest rates, stock prices, or currencies. Think of them as bets or insurance policies that can create future cash payments; they matter to investors because they can cause sudden changes in a company’s reported debt, profits and cash flow and reveal exposure to market risks that could affect valuation.
Series A Preferred stock financial
"Series A Preferred stock, par value $0.001 stated value $100, 100,000 and 0 shares authorized"
Series A preferred stock is a type of ownership share in a company that gives investors certain advantages, such as priority in receiving profits or getting their money back if the company is sold or goes bankrupt. It is often issued during early funding stages to attract investors by offering more security than common shares. This stock matters to investors because it provides a safer way to invest while still holding potential for future gains.
Series B Preferred stock financial
"Series B Preferred stock, par value $0.001 stated value $100, 80,000 and 0 shares authorized"
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
right-of-use assets financial
"Right-of-use assets, net | | | 1,667,693 | | | | 2,000,092 |"
Right-of-use assets are the rights a company gains to use a physical space or equipment under a lease agreement. They are recorded as assets on the company's balance sheet, reflecting the value of future benefits from the leased item. For investors, these assets provide a clearer picture of a company's obligations and resources related to leasing arrangements, helping to assess its financial health and operational commitments.
stock-based compensation financial
"Stock-based compensation | | | 543,068 | | | | 414,900 |"
Stock-based compensation is when a company pays employees, directors or consultants with shares or the right to buy shares instead of or in addition to cash. It matters to investors because issuing stock or options spreads ownership thinner (like cutting a pie into more slices), which can reduce each existing share’s claim on profits and can also change reported earnings; investors watch it to assess true cost of running the business and how management is incentivized.
Offering Type earnings_snapshot
false 0001837254 0001837254 2026-03-30 2026-03-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): March 30, 2026

 

Functional Brands Inc.

(Exact name of Registrant as Specified in its Charter)

 

Delaware   001-42936   85-4094332
(State or other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

6400 SW Rosewood Street

Lake Oswego, Oregon 97035

(Address of Principal Executive Offices) (Zip Code)

 

(Registrant’s Telephone Number, Including Area Code): (800) 245-8282

 

N/A

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.00001 par value share   MEHA   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition. 

 

On March 30, 2026, Functional Brands, Inc. (the “Company”), issued a press release regarding the Company’s financial results for its fourth fiscal quarter and fiscal year ended December 31, 2025, and certain recent corporate developments. A copy of the Company’s press release is attached hereto as Exhibit 99.1. 

 

The information under this Item 2.02 is being furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
99.1   Description Press Release dated March 30, 2026
104   Cover Page Interactive Data File (Embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: March 30, 2026 Functional Brands Inc.
     
  By: /s/ Eric Gripentrog
  Name:  Eric Gripentrog
  Title: Chief Executive Officer

 

 

2

 

 

Exhibit 99.1

 

 

Functional Brands Announces Fourth Quarter and Full-Year 2025 Financial Results

 

Fourth quarter net income improved to $0.9 million compared to a net loss of $0.3 million in the prior year period

 

Lake Oswego, OR – (March 30, 2026) – Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the fourth quarter and full-year ended December 31, 2025.

 

Fourth Quarter 2025 highlights

 

Revenue of $1.50 million compared to $1.68 million in the prior year period, a decrease of approximately 11.0%. This decrease was primarily due to the shift in our Amazon business model from a reseller model to a direct-to-consumer approach through our own Amazon Seller’s Central account.

 

Gross profit was $0.67 million compared to $0.99 million in the prior year period. Gross margin of 44.9% was down 1400 basis points versus the prior year period due to changes in the Amazon business model and inventory adjustments related to our transition out of the hemp business.

 

Net income of $0.9 million or $0.01 per diluted share compared to a net loss of $0.3 million and $(0.08) per diluted share in the prior year period.

 

Full Year 2025 highlights

 

Revenue of $6.61 million compared to $6.57 million in the prior year, an increase of approximately 0.7%, reflecting the inherent stability of the Kirkman business.

 

Gross profit was $3.48 million compared to $3.61 million in the prior year. Gross margin of 52.7% was down 220 basis points versus the prior year due to inventory adjustments related to our transition out of the hemp business.

 

Net income of $0.8 million or $0.01 per diluted share compared to a net loss of $0.6 million and $(0.08) per diluted share in the prior year.

 

“We were pleased to deliver another year of strong bottom-line results as we continue to transform our business model,” said Eric Gripentrog, CEO of Functional Brands Inc. “Over the past several months, we’ve executed a series of key initiatives that mark a pivotal period in the Company’s evolution and establish a strong foundation for sustainable, profitable growth in the future. We achieved significant strategic breakthroughs that differentiate us in the marketplace and demonstrate our commitment to innovation across multiple fronts.

 

 

 

 

“In February, we launched Tru2u.health, our comprehensive digital health platform that integrates peptide solutions, GLP-1-based weight management programs, board-certified telehealth support, and clean supplements into a seamless consumer experience, providing us with a scalable, digitally native growth engine. We also expanded our Kirkman brand portfolio with two innovative product bundles - our Skin, Beauty & Anti-Aging Bundle in December and our Detox Aid Bundle in January. Additionally, we forged a strategic partnership with iHerb to make P2i by Kirkman available to international consumers across Asia, Europe, the Middle East, and Latin America, dramatically expanding our addressable market for the world’s cleanest prenatal vitamin. These accomplishments demonstrate strong execution against our strategic goals and underscore our commitment to our mission of ‘Making Everyone Healthy Again’.”

 

About Functional Brands Inc.

 

Functional Brands Inc. is a health and wellness company focused on acquiring and growing science-based consumer brands. With a portfolio that includes trusted names like Kirkman®, P2i by Kirkman®, Tru2u.Health™; Functional Brands is committed to providing high-quality, effective solutions that support healthier lives.

 

For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health

 

Investor Relations Contact:

 

FunctionalBrands@icrinc.com

 

Cautionary Note Regarding Forward Looking Statements

 

This news release and statements of Functional Brands’ management in connection with this news release or related events contain or may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “potential,” “will,” “should,” “could,” “would,” “optimistic” or “may” and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management’s current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.

 

Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands’ Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company’s Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

 

2

 

 

FUNCTIONAL BRANDS INC.

CONSOLIDATED BALANCE SHEETS (AUDITED)

(In U.S. dollars, except share data or otherwise noted)

 

   December 31,
2025
   December 31,
2024
 
Assets        
Current assets:        
Cash  $2,726,696   $211,642 
Accounts receivable, net   518,474    303,471 
Inventories, net   1,549,511    1,709,458 
Prepaid expenses and other current assets   392,999    45,112 
Deferred offering costs   -    588,641 
Total current assets   5,187,680    2,858,324 
Noncurrent assets:          
Property and equipment, net   37,379    49,564 
Right-of-use assets, net   1,667,693    2,000,092 
Intangible assets, net   1,397,411    1,443,541 
Goodwill   818,139    818,139 
Total non-current assets   3,920,622    4,311,336 
Total assets  $9,108,302   $7,169,660 
           
Liabilities and stockholders’ equity / (deficit)          
Current liabilities:          
Accounts payable and accrued liabilities  $1,554,243   $1,956,165 
Line of credit   8,109    32,235 
SBA loan, current   3,595    3,436 
Lease liabilities, current   371,272    291,213 
Other current liabilities   41,828    35,332 
Derivative liabilities   3,306,745    - 
Payable for acquisition, current   -    2,342,366 
Loans payable (related party), current   61,642    370,703 
Loans payable   402,650    171,500 
Total current liabilities   5,750,084    5,202,950 
Non-current liabilities:          
Lease liabilities, net of current   1,435,505    1,844,819 
SBA loan, net of current   136,873    140,468 
Loan payable (related party), net of current   244,509    - 
Convertible debenture   -    100,000 
Total non-current liabilities   1,816,887    2,085,287 
Total liabilities   7,566,971    7,288,237 
           
Stockholders’ equity / (deficit)          
Series A Preferred stock, par value $0.001 stated value $100,  100,000 and 0 shares authorized as of December 31, 2025 and 2024; 87,445 and 0 shares issued and outstanding, respectively   87    - 
Series B Preferred stock, par value $0.001 stated value $100, 80,000 and 0 shares authorized as of December 2025 and 2024; 28,475 shares issued and 0 outstanding, respectively   28    - 
Common stock, par value $0.00001, 220,000,000 shares authorized; 18,704,649 and 6,694,880 shares issued and outstanding at December 31, 2025 and 2024   187    67 
Additional paid-in capital   8,522,354    7,542,286 
Accumulated deficit   (6,981,325)   (7,660,930)
Total stockholders’ equity / (deficit)   1,541,331    (118,577)
Total liabilities and stockholders’ equity / (deficit)  $9,108,302   $7,169,660 

 

3

 

 

FUNCTIONAL BRANDS INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(In U.S. dollars, except share data or otherwise noted)

 

    (UNAUDITED)
Three Months Ended
December 31,
    (AUDITED)
Year Ended
December 31,
 
    2025     2024     2025     2024  
Revenue, net of returns   $ 1,494,521     $ 1,680,096     $ 6,611,484     $ 6,566,455  
Cost of goods sold     823,766       690,623       3,127,518       2,959,609  
Gross profit     670,755       989,473       3,483,966       3,606,846  
Operating expenses                                
Sales and marketing     169,869       121,601       632,414       576,315  
General and administrative expenses     1,633,636       1,003,619       4,250,124       3,259,623  
Total operating expenses     1,803,505       1,125,220       4,882,538       3,835,938  
Operating income / (loss)     (1,132,750 )     (135,747 )     (1,398,572 )     (229.092 )
Interest expense     (80,982 )     (142,284 )     (402,398 )     (331.836 )
Other income – ERTC refund     -       -       419,947       -  
Other income     -       -       112       -  
Interest income     1,352       281       74,696       1,572  
Change in fair value of derivative liabilities     7,358,935       -       7,358,935       -  
Loss on issuance of preferred stock derivative liability     (5,294,242 )     -       (5,294,242 )     -  
Total other income / (expenses)     1,985,063       (142,003 )     2,157,050       (330.264 )
Net income / (loss)   $ 852,313     $ (277,750 )   $ 758,478     $ (559,356 )
Net income (loss) per share of common stock attributable to common stockholders                                
Basic   $ 0.08     $ (0.08 )   $ 0.08     $ (0.08 )
Diluted   $ 0.01     $ (0.08 )   $ 0.01     $ (0.08 )
Weighted average shares used in computing net loss per share of common stock                                
Basic     8,241,266       6,694,880       8,241,266       6,694,880  
Diluted     85,120,861       6,694,880       85,120,861       6,694,880  

 

4

 

 

FUNCTIONAL BRANDS INC.

CONSOLIDATED STATEMENTS OF CASH FLOW (AUDITED)

(In U.S. dollars, except share data or otherwise noted)

 

   Year Ended
December 31,
 
   2025   2024 
         
Cash flows from operating activities:        
Net income (loss)  $758,478   $(559,356)
Reconcile net income (loss) to cash (used in) provided by operating activities          
Allowance for doubtful accounts receivable   (3,796)   (32,491)
Allowance for inventory obsolescence   53,855    (14,206)
Depreciation of property and equipment   20,698    48,371 
Amortization of right-of-use assets   332,399    306,935 
Amortization of intangible assets   46,130    46,130 
Financing expense on warrant issuance   45,413    - 
Stock-based compensation   543,068    414,900 
Change in fair value of derivative liabilities   (7,358,935)   - 
Loss on issuance of preferred stock of derivative liabilities   5,294,242    - 
Issuance of shares for note extension   80,500    - 
Issuance of common stock for convertible debenture   122,331    - 
Issuance of shares for financing expense   50,629    - 
Changes in operating assets and liabilities:          
Accounts receivable   (211,207)   (100,042)
Inventories   106,092    (1,233)
Prepaid expenses and other current assets   (347,887)   27,329 
Accounts payable and accrued liabilities   (480,795)   132,161 
Other current liabilities   6,496    (5,493)
Lease liabilities   (329,255)   (261,015)
Net cash (used in) provided by operating activities   (1,271,544)   1,990 
           
Cash flows from investing activities:          
Purchase of property and equipment   (8,513)   (1,881)
Net cash used in investing activities:   (8,513)   (1,881)
           
Cash flows from financing activities:          
Deferred offering costs   (1,721,228)   (163,125)
Proceeds from loans   489,324    301,500 
Payments for payable for acquisition   (2,342,366)   (255,002)
Proceeds from debt facilities   99,733    180,662 
Repayment of loans   (422,727)   (6,931)
Proceeds from issuance of preferred stock   8,000,000    - 
Buyback of preferred stock   (180,330)   - 
Line of credit repayment   (123,859)   (216,742)
SBA loan repayment   (3,436)   (3,264)
Net cash provided by (used in) financing activities   3,795,111    (162,902)
           
Increase (decrease) in cash   2,515,054    (162,793)
Cash beginning of period   211,642    374,435 
Cash, end of period  $2,726,696   $211,642 
           
Supplemental disclosures of cash flow information          
Cash paid for interest  $401,411   $224,428 
           
Non-cash investing and financing activities          
Recognition of derivative liability of preferred stock  $13,294,242   $- 
Conversion of preferred stock resulting in a non-cash reduction of the derivative liability recorded to APIC   2,628,242    - 
Fair value adjustment decreasing derivative liability   7,358,935      
Change in Preferred Stock   115    - 
Conversion of preferred stock   112    - 
Deferred offering costs   (2,309,869)   - 
Declaration of preferred stock dividend recorded as an increase in accrued liabilities   78,873    - 
Common stock issued for convertible note payable and accrued interest   122,331    - 
Loan payable, related party  $225,000   $- 

 

5

 

FAQ

How did Functional Brands Inc. (MEHA) perform financially in 2025?

Functional Brands reported net income of $758,478 for 2025, compared with a net loss of $559,356 in 2024. Annual revenue was $6,611,484, slightly above $6,566,455 a year earlier, reflecting a profitability turnaround on relatively stable sales.

What were Functional Brands Inc. (MEHA) fourth-quarter 2025 results?

In the fourth quarter of 2025, Functional Brands generated revenue of $1,494,521 and net income of $852,313. This compares with revenue of $1,680,096 and a net loss of $277,750 in the fourth quarter of 2024, showing improved bottom-line performance.

How did Functional Brands Inc. (MEHA) strengthen its cash position in 2025?

Cash increased to $2,726,696 at December 31, 2025, from $211,642 a year earlier. The main driver was financing activities, including $8,000,000 of proceeds from issuance of preferred stock, partly offset by acquisition payments, loan repayments, and deferred offering costs.

What happened to Functional Brands Inc. (MEHA) stockholders’ equity in 2025?

Stockholders’ equity improved to $1,541,331 at year-end 2025 from a deficit of $118,577 in 2024. This shift reflects new preferred and common equity, additional paid-in capital, and the impact of derivative liability remeasurements alongside the year’s net income.

How did derivative liabilities affect Functional Brands Inc. (MEHA) 2025 results?

Functional Brands reported derivative liabilities of $3,306,745 at December 31, 2025 and a favorable $7,358,935 change in fair value during the year. It also recorded a $5,294,242 loss on issuance of preferred stock derivative liability, making derivatives a major factor in reported other income.

What were Functional Brands Inc. (MEHA) operating cash flows for 2025?

Net cash used in operating activities was $(1,271,544) for 2025, despite positive net income. Reconciliation items included non-cash derivative liability adjustments, stock-based compensation of $543,068, lease-related amortization, working capital movements, and other non-cash financing-related entries.

Filing Exhibits & Attachments

4 documents
Functional Brands Inc

NASDAQ:MEHA

View MEHA Stock Overview

MEHA Rankings

MEHA Latest News

MEHA Latest SEC Filings

MEHA Stock Data

3.33M
19.91M
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
WEST HOLLYWOOD